SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 215 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $44 | +18.9% | 25,330 | +119.6% | 0.00% | – |
| Q4 2022 | $37 | -100.0% | 11,533 | -71.5% | 0.00% | -100.0% |
| Q3 2022 | $198,000 | +395.0% | 40,482 | +314.4% | 0.00% | – |
| Q2 2022 | $40,000 | -27.3% | 9,769 | +7.7% | 0.00% | – |
| Q1 2022 | $55,000 | -12.7% | 9,071 | +7.5% | 0.00% | – |
| Q4 2021 | $63,000 | -11.3% | 8,435 | +7.9% | 0.00% | – |
| Q3 2021 | $71,000 | -23.7% | 7,817 | 0.0% | 0.00% | – |
| Q2 2021 | $93,000 | -4.1% | 7,817 | 0.0% | 0.00% | – |
| Q1 2021 | $97,000 | -20.5% | 7,817 | 0.0% | 0.00% | – |
| Q4 2020 | $122,000 | +64.9% | 7,817 | 0.0% | 0.00% | – |
| Q3 2020 | $74,000 | +5.7% | 7,817 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | +40.0% | 7,817 | 0.0% | 0.00% | – |
| Q1 2020 | $50,000 | -23.1% | 7,817 | 0.0% | 0.00% | – |
| Q4 2019 | $65,000 | -44.0% | 7,817 | -27.7% | 0.00% | – |
| Q2 2019 | $116,000 | -4.1% | 10,811 | -15.3% | 0.00% | – |
| Q1 2019 | $121,000 | -14.2% | 12,767 | 0.0% | 0.00% | – |
| Q4 2018 | $141,000 | -34.7% | 12,767 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $216,000 | +19.3% | 12,767 | 0.0% | 0.00% | – |
| Q2 2018 | $181,000 | -25.2% | 12,767 | 0.0% | 0.00% | -100.0% |
| Q1 2018 | $242,000 | +15.8% | 12,767 | 0.0% | 0.00% | – |
| Q4 2017 | $209,000 | +14.8% | 12,767 | 0.0% | 0.00% | – |
| Q3 2017 | $182,000 | +304.4% | 12,767 | +150.3% | 0.00% | – |
| Q2 2017 | $45,000 | +73.1% | 5,100 | 0.0% | 0.00% | – |
| Q1 2017 | $26,000 | +73.3% | 5,100 | 0.0% | 0.00% | – |
| Q4 2016 | $15,000 | -68.8% | 5,100 | -50.0% | 0.00% | – |
| Q3 2016 | $48,000 | +65.5% | 10,200 | +100.0% | 0.00% | – |
| Q2 2016 | $29,000 | -6.5% | 5,100 | 0.0% | 0.00% | – |
| Q1 2016 | $31,000 | -34.0% | 5,100 | 0.0% | 0.00% | – |
| Q4 2015 | $47,000 | +62.1% | 5,100 | 0.0% | 0.00% | – |
| Q3 2015 | $29,000 | -48.2% | 5,100 | 0.0% | 0.00% | – |
| Q2 2015 | $56,000 | -30.0% | 5,100 | 0.0% | 0.00% | – |
| Q1 2015 | $80,000 | +3.9% | 5,100 | 0.0% | 0.00% | – |
| Q4 2014 | $77,000 | +40.0% | 5,100 | 0.0% | 0.00% | – |
| Q3 2014 | $55,000 | -29.5% | 5,100 | 0.0% | 0.00% | – |
| Q2 2014 | $78,000 | -15.2% | 5,100 | 0.0% | 0.00% | – |
| Q1 2014 | $92,000 | +29.6% | 5,100 | 0.0% | 0.00% | – |
| Q4 2013 | $71,000 | – | 5,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |